Tumor microenvironment: The culprit for ovarian cancer metastasis?

Zhongyue Luo1, Qiu Wang2, Wayne Bond Lau3

  • 1Department of Obstetrics and Gynecology, Key Laboratory of Obstetrics & Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second Hospital and The State Key Laboratory of Biotherapy/Collaborative Innovation Center, West China Hospital, Sichuan University, Chengdu, 610041, China.

Cancer Letters
|May 2, 2016
PubMed

Insights

Ovarian cancer metastasis is driven by complex interactions within the tumor microenvironment. Understanding these signals between cancer cells and stroma can reveal new diagnostic and therapeutic targets.

Area of Science:

  • Oncology
  • Cancer Biology
  • Molecular Mechanisms

Background:

  • Ovarian cancer frequently recurs and disseminates despite current treatments, with poor patient prognosis.
  • The molecular underpinnings of ovarian cancer metastasis remain incompletely understood.
  • The tumor microenvironment (TME) plays a critical role in cancer progression.

Purpose of the Study:

  • To comprehensively review the reciprocal signaling between ovarian cancer cells and the tumor stroma.
  • To elucidate the molecular mechanisms driving ovarian cancer metastasis via the TME.
  • To identify potential diagnostic biomarkers and therapeutic targets for ovarian cancer.

Main Methods:

  • Literature review of recent evidence on tumor microenvironment and ovarian cancer metastasis.
  • Analysis of the components of the tumor microenvironment, including stromal cells, extracellular matrix, and exosomes.
  • Examination of the autocrine-paracrine communication circuits within the TME.

Main Results:

  • The tumor microenvironment, comprising stromal cells, extracellular matrix, and exosomes, establishes communication circuits that promote ovarian cancer invasion and metastasis.
  • Reciprocal signaling between tumor stroma and ovarian cancer cells is a significant contributor to metastasis.
  • Specific components like inflammatory cytokines, chemokines, and matrix metalloproteinases are implicated in facilitating metastasis.

Conclusions:

  • The tumor microenvironment is a key driver of ovarian cancer metastasis.
  • Understanding the intricate signaling networks within the TME is crucial for developing effective treatments.
  • This review provides insights for novel diagnostic biomarkers and therapeutic strategies for ovarian cancer.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
The Tumor Microenvironment02:17

The Tumor Microenvironment

3.0K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K